Home The crystal structure of 1-methyl-N-(1-methyl-1H-imidazole-2-carbonyl)-1H-imidazole-2-carboxamide, C10H11N5O2
Article Open Access

The crystal structure of 1-methyl-N-(1-methyl-1H-imidazole-2-carbonyl)-1H-imidazole-2-carboxamide, C10H11N5O2

  • Jing Nie ORCID logo EMAIL logo , Mou Jiahui and Wang Wenxiang ORCID logo
Published/Copyright: October 24, 2022

Abstract

C10H11N5O2, orthorhombic, Pca21 (no. 29), a = 22.6173(13) Å, b = 4.8730(3) Å, c = 9.9921(5) Å, V = 1101.27(11) Å3, Z = 4, Rgt (F) = 0.0440, wRref (F 2) = 0.0999, T = 200(2) K.

CCDC no.: 2204664

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless prism
Size: 0.36 × 0.18 × 0.14 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.10 mm−1
Diffractometer, scan mode: Rigaku SCXmini, ω
θ max, completeness: 27.5°, 99%
N(hkl)measured, N(hkl)unique, R int: 9422, 2514, 0.062
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 1893
N(param)refined: 160
Programs: Rigaku [1], Olex2 [2], SHELX [3, 4], Diamond [5]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
O1 0.62241 (11) 0.2754 (5) 0.3186 (2) 0.0487 (7)
O2 0.71828 (11) 0.5702 (6) 0.4308 (3) 0.0598 (8)
N1 0.64554 (12) 1.0242 (6) 0.6563 (3) 0.0398 (7)
N3 0.61961 (13) 0.6080 (6) 0.4818 (3) 0.0374 (6)
N5 0.49537 (11) 0.1962 (5) 0.3633 (2) 0.0344 (6)
C1 0.67431 (17) 1.1990 (8) 0.7413 (3) 0.0473 (9)
H1 0.655297 1.327570 0.798346 0.057*
C4 0.68851 (14) 0.8859 (7) 0.5959 (3) 0.0348 (7)
C5 0.67876 (15) 0.6744 (7) 0.4949 (3) 0.0385 (8)
C6 0.59508 (14) 0.4048 (7) 0.4022 (3) 0.0352 (7)
C7 0.53172 (13) 0.3713 (6) 0.4284 (3) 0.0324 (7)
C8 0.50937 (15) −0.0042 (8) 0.2583 (3) 0.0396 (8)
H8A 0.514130 0.091038 0.172602 0.059*
H8B 0.477156 −0.137847 0.251260 0.059*
H8C 0.546187 −0.099464 0.281020 0.059*
C3 0.80109 (15) 0.8593 (9) 0.6008 (4) 0.0579 (11)
H3A 0.831987 0.962287 0.647759 0.087*
H3B 0.806373 0.879858 0.503975 0.087*
H3C 0.803822 0.664707 0.624840 0.087*
N2 0.74294 (12) 0.9653 (6) 0.6394 (2) 0.0390 (7)
C2 0.73397 (17) 1.1635 (8) 0.7329 (3) 0.0458 (9)
H2 0.763403 1.258361 0.782576 0.055*
N4 0.50276 (12) 0.5213 (6) 0.5187 (3) 0.0383 (6)
C10 0.44543 (15) 0.4393 (8) 0.5080 (4) 0.0446 (9)
H10 0.413622 0.511276 0.559240 0.053*
C9 0.44012 (14) 0.2400 (7) 0.4138 (4) 0.0426 (8)
H9 0.404793 0.148751 0.388029 0.051*
H3 0.5933 (19) 0.694 (8) 0.544 (4) 0.066 (13)*

Source of materials

All chemicals were purchased from commercial sources and used as received without further purification. In a 25 mL reaction vessel, a solution of (1H-imidazol-2-yl)methanamine (10 mmol), copper acetate (2 mmol), 80 mL of toluene was added to a 150 mL round bottom flask. The resulted mixture was stirred for 24 h in an ice bath under the protection of nitrogen atmosphere. The solvent is removed by evaporation and then extracted by dichloromethane. Finally, the samples were purified by recrystallization. Yield: 3.80 g, 86%.

Experimental details

All H atoms bond to C atoms were introduced using the Hfix command in the Shelxl-2014 program [1], with the value of 0.93 Å or 0.96 Å for C–H bonds distances. All H atoms were allowed for as riding atoms with U iso(H) = 1.2U eq(C) or U iso(H) = 1.5U eq(C) for hydrogen atoms bonded to imidazole ring and methyl group, respectively.

Comment

Amide type compounds are important chemical intermediates in organic chemistry, which play an important role in medicinal chemistry, life science and other fields [6], [7], [8]. Owing to strong intermolecular hydrogen bonding, amide type compounds have irreplaceable functional properties [9]. Up to now, Amide structure has a high occupancy of constant high (more than 25%) in the known pharmacochemical analysis database. Imidazole is a class of important nitrogen-containing heterologous compound, which form hydrogen bonds with receptors and enzymes in organisms by the special thick ring structure of imidazole. The advantages of amide group structure combined with the properties of imidazole fully exploit its potential in biological function. Up to date, a great number of imidazole amide compounds have been reported [10], [11], [12], [13]. However, there are relatively few reports about diimidazole amides compounds. Herein, we report the crystal structure of a new imidazole-based amide compound, which was synthesized by simple method in high yield.

The single X-ray diffraction analysis shows that the crystal structure agrees well with the expected structure of the title compound 1 (see the structure drawing). The two imidazole cores as the main bodies are connected with the N-formylforamide group. The N-formylformamide bond distances are 1.386(4) Å for C6–N3 and 1.383(4) Å for C5–N3. The C6–N3–C5 bond angel is 127.5(3) Å. The O1–C6 and O2–C5 bond distances are 1.215(4) and 1.211(4) Å, respectively. The N3–C6–O1 and N3–C5–O2 bond angels are 124.2(3) and 124.5(3) Å.


Corresponding author: Jing Nie, Jiangsu Vocational Institute of Architectural Technology, Xuzhou 221116, People’s Republic of China, E-mail:

Funding source: Higher Education Institutions of Jiangsu Province

Award Identifier / Grant number: 21KJB50037

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Foundation of the Higher Education Institutions of Jiangsu Province (21KJB50037), China.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku. CrystalClear SM Expert; Rigaku Corporation: Tokyo, Japan, 2005.Search in Google Scholar

2. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K., Puschmann, H. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment – Olex2 dissected. Acta Crystallogr. 2015, A71, 59–75; https://doi.org/10.1107/s2053273314022207.Search in Google Scholar

3. Sheldrick, G. M. SHELXT – integrated space-group and crystal structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

4. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

5. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Search in Google Scholar

6. Guo, D., Zhou, X., Muhammad, N., Huang, S., Zhu, Y. An overview of poly (amide-amine) dendrimers functionalized chromatographic separation materials. J. Chromatogr. A 2022, 1669, 462960–462972; https://doi.org/10.1016/j.chroma.2022.462960.Search in Google Scholar PubMed

7. Alfano, A. I., Lange, H., Brindisi, M. Amide bonds meet flow chemistry: a journey into methodologies and sustainable evolution. ChemSusChem 2022, 15, 202102708; https://doi.org/10.1002/cssc.202200301.Search in Google Scholar PubMed

8. Meng, G., Shi, S., Lalancette, R., Szostak, R., Szostak, M. Reversible twisting of primary amides via ground state N–C(O) destabilization: highly twisted rotationally inverted acyclic amides. J. Am. Chem. Soc. 2018, 140, 727–734; https://doi.org/10.1021/jacs.7b11309.Search in Google Scholar PubMed

9. Sharma, P., LaRosa, C., Antwi, J., Govindarajan, R., Werbovetz, K. A. Imidazoles as potential anticancer agents: an update on recent studies. Molecules 2021, 26, 4213; https://doi.org/10.3390/molecules26144213.Search in Google Scholar PubMed PubMed Central

10. Mino, T., Sakamoto, S., Hamachi, I. Recent applications of N-acyl imidazole chemistry in chemical biology. Biosci. Biotechnol. Biochem. 2021, 85, 53–60; https://doi.org/10.1093/bbb/zbaa026.Search in Google Scholar PubMed

11. Masuoka, N., Lei, C., Li, H., Hisatsune, T. Influence of imidazole-dipeptides on cognitive status and preservation in elders: a narrative review. Nutrients 2021, 13, 397; https://doi.org/10.3390/nu13020397.Search in Google Scholar PubMed PubMed Central

12. Olson, K. L., Holt, M. C., Ciske, F. L., Kramer, J. B., Heiple, P. E., Collins, M. L., Johnson, C. M., Ho, C. S., Morano, M. I., Barrett, S. D. Novel amide and imidazole compounds as potent hematopoietic prostaglandin D2 synthase inhibitors. Bioorg. Med. Chem. Lett. 2021, 34, 127759; https://doi.org/10.1016/j.bmcl.2020.127759.Search in Google Scholar PubMed

13. Bohlender, C., Wolfram, M., Goerls, H., Imhof, W., Menzel, R., Baumgaertel, A., Schubert, U. S., Mueller, U., Frigge, M., Schnabelrauch, M., Wyrwa, R., Schiller, A. Light-triggered NO release from a nanofibrous non-woven. J. Mater. Chem. 2012, 22, 8785–8792; https://doi.org/10.1039/c2jm15410b.Search in Google Scholar

Received: 2022-09-20
Accepted: 2022-10-10
Published Online: 2022-10-24
Published in Print: 2022-12-16

© 2022 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of 1,5-bis(4-chlorophenyl)-3-(3-methylphenyl)pentane- 1,5-dione, C48H40Cl4O4
  4. Crystal structure of (bis(1,10-phenanthroline-κ 2 N,N′))-(3,5-dinitrosalicylato-κ 2 O,O′)nickel(II), C31H18N6NiO7
  5. Crystal structure of {N,N′-bis(4-fluoro-salicylaldehyde)-3,6-dioxa-1,8-diaminooctane-κ4 O,N,N′,O′}zinc(II), C20H20F2N2O4Zn
  6. [5-Bromo-2-(2-(dimethylamino)ethyliminomethyl)phenolato-κ3 N,N′,O]-isothiocyanato-nickel(II), C12H14BrN3NiOS
  7. Crystal structure of 9-bromo-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin- 2-amine, C18H15BrN4O
  8. The crystal structure of imidazolium nitrate, C3H5O3N3
  9. Crystal structure of diiodido-bis(6,6′-dimethoxy-2,2′-(ethane-1,2-diylbis(nitrilomethanylylidene)) diphenolato)tricadmium(II), C36H36Cd3I2N4O8
  10. Crystal structure of [diaqua-bis(2-((1H-tetrazol-1-yl)methyl)-5-carboxy-1H-imidazole-4-carboxylato-κ2 N,O) manganese(II)] dihydrate, C14H18MnN12O12
  11. Crystal structure of Diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-k4 O,O′,N,N′)]iron(II), C13H14FeN4O10
  12. Crystal structure of poly[dimethanol-κ1O-(µ2-(E)-2-((2-oxidobenzylidene)amino)acetato)-(µ3-(E)-2-((2-oxidobenzylidene)amino)acetato)dicadmium(II)], C20H22Cd2N2O8
  13. Crystal structure of N 2,N 6-bis(2-(((E)-quinolin-8-ylmethylene)amino)phenyl)pyridine-2,6-dicarboxamide, C39H27N7O2
  14. An I 6 2 anion in the crystal structure of theophyllinium triiodide monohydrate, C7H11I3N4O3
  15. The crystal structure of poly[6,6′-oxybis(4-(pyridin-1-ium-1-yl)-1,3,5,2,4,6-trioxatriborinan-2-olate)], [B6O9](C5H5N)2
  16. The crystal structure of (carbonato κ2 O,O′)(2-oxopyridin-1(2H)-olato-κN)tris(trimethylphosphine)rhodium(III) water solvate, C15H33NO5P3Rh
  17. The crystal structure of dibromido-bis((RS)-2-(4-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)hexanenitrile-κ1 N)zinc(II), C30H34Br2Cl2N8Zn
  18. Synthesis and crystal structure of 3-(((7-hydroxy-3-(4-hydroxy-3,5-dinitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)(nitroso)amino)propanoic acid, C19H14N4O11
  19. The crystal structure of 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate, C18H20ClNO5S
  20. Crystal structure of di([1,1′:3′,1″-terphenyl]-2′-yl)tellane, C36H26Te
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]-pyrimidine-3-carboxylato-κ2 N,O)zinc(II), C14H12N6O6Zn
  22. Crystal structure of N′,N‴-((1E,2E)-1,2-diphenylethane-1,2-diylidene)bis(4-methylbenzohydrazide) – water – methanol (1/1/1), C31H32N4O4
  23. Crystal structure of 3-((2,4-dichlorobenzyl)thio)-5-methyl-7-(trifluoromethyl)-[1,2,4]triazolo [4,3-c]pyrimidine, C14H9Cl2F3N4S
  24. Crystal structure of 3,5,6,7-tetramethoxy-3′,4′-methylenedioxy-flavone, C20H18O8
  25. Crystal structure of catena-poly[(5,5′-dimethyl-2,2′-bipyridine-κ 2 N,N′)-(μ 3-hydrogen-1,1′,1″-(1,3,5-triazine-2,4,6-triyl)tris(piperidine-4-carboxylato)- κ 5 O:O,O′:O″,O‴)-cadmium(II)], C33H40CdN8O6
  26. The crystal structure of 3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C9H17N3
  27. Crystal structure of [(1,4,7,10-tetraoxacyclododecane-κ 4 O,O′,O″, O‴)-tris(nitrato-κ 2 O,O′)gadolinium(III)], C8H16N3O13Gd
  28. The crystal structure of 2,2′-((pyridine-2,6-diylbis(methylene))bis(sulfanediyl))-bis(4,5-dihydro-1H-imidazol-3-ium) bromide, C13H19Br2N5S2
  29. Crystal structure of E-2-chloro-N′-(1-(5-chloro-2-hydroxyphenyl)propylidene)benzohydrazide, C16H14Cl2N2O2
  30. Crystal structure of 3-(adamantan-1-yl)-4-methyl-5-{[(4-nitrophenyl)methyl]sulfanyl}-4H-1,2,4-triazole, C20H24N4O2S
  31. The crystal structure of dimethanol-κ1O-(5,10,15,20-tetrakis(4-nitrophenyl)porphyrin-21,23-diido-κ4 O,O′,O″,O′″)manganese(III) trans-dicyanido-κ1C-bis(acetylacetonato-κ2 O,O′)ruthenium(III), C58H46N10O14RuMn
  32. The crystal structure of nitroxyl-κ N-{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl-κN 3)borato}nickel(II), C15H13BF9N7NiO
  33. The crystal structure of [(2,2′-bipyridine-κ2 N,N)-bis(6-phenylpyridine-2-carboxylato- κ2 N,O)nickel(II)] monohydrate, C34H26N4O5Ni
  34. The crystal structure of 5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione, C20H15F5N2O3
  35. The crystal structure of ethyl 2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)benzoate, C14H12F3NO3
  36. [2,2′-{Ethane-1,2-diylbis[(azanylylidene)methanylylidene]}bis(3-bromo-2-hydroxyphenyl)]iron(III) nitrate, C20H12Br2CuN2O2
  37. The crystal structure of 1-(2-iodophenyl)-4-phenyl-1H-1,2,3-triazole, C14H10IN3
  38. Synthesis and crystal structure of 2-(2-oxo-2-(thiophen-2-yl)ethyl)-4H-chromen-4-one, C15H10O3S
  39. {6,6′-((1E,1′E)-((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-bromo-4-chlorophenolate)-κ4N,N′,O,O′}copper(II), C19H16Br2Cl2CuN2O2
  40. The crystal structure of N′-[bis(2-hydroxyphenyl)methylidene]pyridine-4-carbohydrazide, C19H15N3O3
  41. Crystal structure of 2-chloro-6-formylphenolato-κ2O,O′-(6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-chlorophenolato)κ4 N,N,O,O′)cobalt(III), C26H22Cl3CoN2O4
  42. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylate-κ 2 N,O)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 2 O:O′)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 3N,O:O)tetralead(II) C48H32N4O8Pb2
  43. The crystal structure of 3,7-dihydroxy-9-methoxy-4a-methyl-4aH-benzo[c] chromene-2,6-dione —dichloromethane (1/1), C16H14Cl2O6
  44. The crystal structure of (Z)-6-(((5-chloro-2-hydroxyphenyl)amino)methylene)- 4-nitrocyclohexa, C13H9ClN2O4
  45. Crystal structure of dichlorido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ1 N)zinc(II), C60H68O4N12Cl10Zn
  46. The crystal structure of 4-(2-bromoethoxy)-2-hydroxybenzaldehyde, C9H9BrO3
  47. The crystal structure of 5-azido-1-methyl-4-nitroimidazole, C4H4O2N6
  48. Crystal structure of dibromido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ 1 N)zinc(II), C60H68O4N12Br2Cl8Zn
  49. Crystal structure of tetrasodium-bis(μ 2-oxido)-hexafluoro-didioxo-molybdenum(V), Na2(Mo2O4F6)
  50. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-4- hydroxybenzohydrazide-water (1/1), C14H13Cl1N2O4
  51. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinolin-2-yl)methanimine, C20H19N3O
  52. The crystal structure of catena-poly[(1,10-phenanthroline-κ2 N,N′)-(μ3-2-hydroxybenzene-1,3-dicarboxylato-κ5 O,O′:O″,O‴:O‴)cadmium(II)], C20H12CdN2O5
  53. The crystal structure of 2,6-di-tert-butyl-4-(4-(methylthio)benzylidene)cyclohexa-2,5-dien-1-one, C22H28OS
  54. La3.65Mg30Sb1.07 as a disordered derivative of Th2Ni17-type structure
  55. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinoxalin-2-yl)methanimine, C19H18N4O
  56. The crystal structure of 2,2′-(1,2-phenylenebis(methylene))bis(1,3-dimethylisothiouronium) bromide, C14H24Br2N4S2
  57. Crystal structure of tetraaqua-bis[4-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N]zinc(II), C18H20ZnN6O8
  58. Crystal structure of bis(tricarbonyl)-{(S)-(tert-butoxycarbonyl)(1-methoxy-1-oxo-3-sulfido-k2 S:S′-propan-2-yl)amido-k2N:N′}diiron(I) (Fe—Fe), C15H15Fe2NO10S
  59. Crystal structure of (E)-3-((4-chlorophenyl)thio)-4-hydroxypent-3-en-2-one, C11H11ClO2S
  60. The crystal structure of (E)-3′,6′-bis(diethylamino)-2-((5-(diethylamino)-2-hydroxybenzylidene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C39H45N5O3
  61. The crystal structure of 2-(4-methoxynaphthalen-1-yl)-4H-chromen-4-one, C20H14O3
  62. The crystal structure of trans-dichlorido-(ethylenediamine-κ 2 N,N′)-bis(triphenylphosphine-κ 1 P)ruthenium(II), C38H38Cl2N2P2Ru
  63. The double polymeric chain of catena-poly[(μ2-6-bromopyridine-3-carboxylato-κ2 O,O′) (6-bromopyridine-3-carboxylato-κ2 O,O′) (μ2-1,2-bis(4-pyridyl)ethylene-κ2 N:N′)cobalt(II)], C24H16CoBr2N4O4
  64. The crystal structure of tert-butyl 2-(4-(12-bromo [2.2]paracyclophanyl)carbamoyl)pyrrolidine-1-carboxylate, C26H31BrN2O3
  65. The crystal structure of (Z)-2-(2,3-dimethoxybenzylidene)naphtho[1,2-b]furan-3(2H)-one, C21H16O4
  66. Crystal structure of 2-hydroxy-1-tosylindolin-3-yl- 2-naphthoate, C26H21N1S1O5
  67. The crystal structure of 1-methyl-N-(1-methyl-1H-imidazole-2-carbonyl)-1H-imidazole-2-carboxamide, C10H11N5O2
  68. The crystal structure of (E)-2-((5-bromo-2-hydroxybenzylidene)amino)-3′,6′-bis(ethylamino)-2′, 7′-dimethylspiro[isoindoline-1,9′-xanthen]-3-one, C33H31BrN4O3
  69. The crystal structure of dimethanol-5,15-diphenylporphyrin-21,23-diido-κ4 N,Nʹ,Nʺ,Nʹʺ-manganese(III) trans-dicyanido-bis(acetylacetonato-κ2O,Oʹ)ruthenium(III), C46H42N6O6RuMn
  70. Crystal structure of 1,4,8,11-tetraazacyclotetradecane-1,8-diium bis(3,5-dicarboxybenzoate), C28H36N4O12
  71. Bifurcated halogen bonds in the crystal structure of 2,2′-bi(1,8-naphthyridine)—1,4-diiodotetrafluorobenzene (1/1), C22H10F4I2N4
Downloaded on 17.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0461/html?srsltid=AfmBOorkB-0_8Zdyi0vEYw6QrVMgqp07NIaU8rSdi6oFlx9nZwIbQhdF
Scroll to top button